Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Lemoine

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 17, 2025
Pointing Care for Preeclampsia in the Right DirectionElizabeth Lemoine, Ravi Thadhani
Trends in Pharmacological Sciences|January 6, 2019
Affordable Preeclampsia TherapeuticsElizabeth Lemoine, Ravi Thadhani
American Journal of Nephrology|April 15, 2019
Failure in Physiologic Flexibility: Adverse Pregnancy Outcomes in Women with Reduced Renal ReserveElizabeth Lemoine, S Ananth Karumanchi
Circulation Research|March 29, 2019
Preeclampsia: Pathophysiology, Challenges, and PerspectivesSarosh Rana, Elizabeth Lemoine, Joey P Granger, et al.
American Journal of Obstetrics and Gynecology|June 2, 2024
Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testingJimmy Espinoza, Vinicius F Calsavara, Sarah Kilpatrick, et al.
NEJM Evidence|February 6, 2024
Circulating Angiogenic Factor Levels in Hypertensive Disorders of PregnancyRavi Thadhani, Elizabeth Lemoine, Sarosh Rana, et al.
American Journal of Obstetrics and Gynecology|November 13, 2025
Serum soluble fms-like tyrosine kinase kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancyAnders H Berg, Vinicius F Calsavara, Martin Hund, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Hypertension (Dallas, Tex. : 1979)|December 17, 2025
Pointing Care for Preeclampsia in the Right DirectionElizabeth Lemoine, Ravi Thadhani
Trends in Pharmacological Sciences|January 6, 2019
Affordable Preeclampsia TherapeuticsElizabeth Lemoine, Ravi Thadhani
American Journal of Nephrology|April 15, 2019
Failure in Physiologic Flexibility: Adverse Pregnancy Outcomes in Women with Reduced Renal ReserveElizabeth Lemoine, S Ananth Karumanchi
Circulation Research|March 29, 2019
Preeclampsia: Pathophysiology, Challenges, and PerspectivesSarosh Rana, Elizabeth Lemoine, Joey P Granger, et al.
American Journal of Obstetrics and Gynecology|June 2, 2024
Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testingJimmy Espinoza, Vinicius F Calsavara, Sarah Kilpatrick, et al.
NEJM Evidence|February 6, 2024
Circulating Angiogenic Factor Levels in Hypertensive Disorders of PregnancyRavi Thadhani, Elizabeth Lemoine, Sarosh Rana, et al.
American Journal of Obstetrics and Gynecology|November 13, 2025
Serum soluble fms-like tyrosine kinase kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancyAnders H Berg, Vinicius F Calsavara, Martin Hund, et al.
Pageof 1